Phenomics Australia, together with Bioplatforms Australia and Therapeutic Innovation Australia, is proud to celebrate the official launch of the SMART CRC, a landmark initiative driving the future of regenerative therapies in Australia.
Over two fantastic days of collaboration, innovation, and connection, the event brings together industry leaders, world-class researchers, government representatives, and key partners to mark this significant milestone. Phenomics Australia’s Strategic Partnerships Advisor, Dr John Parisot, attended and actively participated, representing our commitment to building strong collaborations that will accelerate regenerative medicine innovation.
With a $238M national initiative, SMART CRC aims to transform regenerative medicine by overcoming critical barriers in manufacturing and access. Phenomics Australia is honoured to stand alongside SMART CRC in advancing this vision and shaping a new era of healthcare.
Regenerative therapies hold the potential to restore normal function, improve quality of life, and save lives, addressing conditions such as cancer, heart disease, and diabetes. Yet, challenges such as high costs, manufacturing bottlenecks, and dependence on overseas solutions limit access for Australian patients. SMART CRC exists to bridge these gaps and ensure that Australians can benefit from these life-changing innovations.
We’re excited about the conversations, energy, and momentum this launch has sparked, and we look forward to continuing this collaboration as we work together to unlock the full potential of regenerative medicine in Australia.
